Phenotypic Characterization Articles & Analysis
2 news found
The company is working on an AI-driven Retinal Deep Phenotyping™ solution to detect chronic disease biomarkers, which can enhance the diagnosis of neurodegenerative conditions such as Alzheimer’s. ...
In the U.S., Dupixent is approved in patients aged 6 years and older with uncontrolled moderate-to-severe atopic dermatitis; as an add-on maintenance treatment of patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid-dependent asthma; and for use with other medicines for the ...